Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study. - Egyptian Knowledge Bank - troweb

119759

Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Could local curative breast surgery improve survival in women with oligometastatic breast cancer?

Article

RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER

Article

Could Local Surgery Improve Survival in Stage IV Breast Cancer?

Article

RESPONSE OF LOCALY ADVANCED BREAST CANCER TO PRIMARY CHEMOTHERAPY; IS IT ELIGIBLE FOR BREAST CONSERVATION

Article

ASSESSMENT OF SURGICAL MANAGEMENT OF FEMALE BREAST CANCER PATIENTS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR INVASIVE DUCTAL VERSUS INVASIVE LOBULAR CARCINOMA (T3 STAGE)

Article

BREAST-CONSERVING TREATMENT IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER

Article

IMPACT OF AXILLARY LYMPH NODES RATIO ON OUTCOMES OF NON METASTATIC, TRIPLE NEGATIVE BREAST CANCER PATIENTS TREATED WITH UP FRONT SURGERY (A RETROSPECTIVE STUDY)

Article

Outcome of liver resection in breast cancer liver metastases

Article

A retrospective study of the effect of neoadjuvant chemotherapy as a primary treatment of advanced breast cancer and its effect on surgical modalities.

Article

Treatment Outcome in Patients with Metastatic Non-Small Cell Lung Cancer at Presentation (Retrospective Study)